Publikationen in Zusammenarbeit mit Forschern von Centro Nacional de Microbiología (37)

2024

  1. Epidemiological and clinical characterization of community, healthcare-associated and nosocomial colonization and infection due to carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Spain

    Infection

  2. Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination regimen against SARS-CoV-2 variants

    iScience, Vol. 27, Núm. 9

  3. Novel risk loci for COVID-19 hospitalization among admixed American populations

    eLife, Vol. 13

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. Excretion and viability of SARS-CoV-2 in feces and its association with the clinical outcome of COVID-19

    Scientific Reports, Vol. 12, Núm. 1

  2. Immune response and reactogenicity after immunization with two-doses of an experimental COVID-19 vaccine (CVnCOV) followed by a third-fourth shot with a standard mRNA vaccine (BNT162b2): RescueVacs multicenter cohort study

    eClinicalMedicine, Vol. 51

  3. Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study

    eClinicalMedicine, Vol. 50

  4. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. Author Correction: Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America (Scientific Reports, (2021), 11, 1, (11442), 10.1038/s41598-021-90023-x)

    Scientific Reports

  2. Azole resistance survey on clinical Aspergillus fumigatus isolates in Spain

    Clinical Microbiology and Infection, Vol. 27, Núm. 8, pp. 1170.e1-1170.e7

  3. Do high MICs predict the outcome in invasive fusariosis?

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 4, pp. 1063-1069

  4. Identification of CRF66_BF, a New HIV-1 Circulating Recombinant Form of South American Origin

    Frontiers in Microbiology, Vol. 12

  5. Identification of CRF89_BF, a new member of an HIV-1 circulating BF intersubtype recombinant form family widely spread in South America

    Scientific Reports, Vol. 11, Núm. 1

  6. Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

    The Lancet, Vol. 398, Núm. 10295, pp. 121-130

2020

  1. Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study

    The Lancet, Vol. 396, Núm. 10250, pp. 535-544

2019

  1. Diagnostic delay as main contributing factor to a large outbreak of tuberculosis in a university

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 37, Núm. 8, pp. 496-501

  2. Method-dependent epidemiological cutoff values for detection of triazole resistance in Candida and Aspergillus species for the Sensititre Yeastone colorimetric broth and etest agar diffusion methods

    Antimicrobial Agents and Chemotherapy, Vol. 63, Núm. 1

2018

  1. Endophthalmitis caused by Fusarium: An emerging problem in patients with corneal trauma. A case series

    Revista Iberoamericana de Micologia, Vol. 35, Núm. 2, pp. 92-96

  2. Epidemiological and clinical characteristics of infants admitted to hospital due to human parechovirus infections: A prospective study in Spain

    Anales de Pediatria, Vol. 88, Núm. 2, pp. 82-88

  3. Scedosporium and Lomentospora: An updated overview of underrated opportunists

    Medical Mycology, Vol. 56, pp. S102-S125